Want to see TNMG full AI Analyst Report?
Top Page
TNL Mediagene
(NASDAQ:TNMG)
Select Model
Select Model
Rating:42Neutral
Price Target:
$0.45
▼(-22.93% Downside)
Action:Reiterated
Date:08/26/26
The score is held down primarily by weak financial performance (deep losses, persistent cash burn, and sharply deteriorated equity/leverage risk). Technical indicators add further caution due to a longer-term downtrend and negative MACD. Valuation does not offset these risks because the company is loss-making (negative P/E) and offers no dividend yield.
Positive Factors
Diversified digital monetization
Multiple monetization channels reduce reliance on a single advertising format. Owned media, branded campaigns, and commerce referrals can diversify revenue and allow audience growth to support several durable sources of advertiser and partner demand.
Negative Factors
Unstable revenue and deep losses
Declining revenue combined with sustained operating and net losses indicates weak operating leverage and limited evidence of a durable path to profitability. Continued underperformance could constrain investment, advertiser confidence, and the company’s ability to scale its media portfolio.
Read all positive and negative factors
Positive Factors
Negative Factors
Diversified digital monetization
Multiple monetization channels reduce reliance on a single advertising format. Owned media, branded campaigns, and commerce referrals can diversify revenue and allow audience growth to support several durable sources of advertiser and partner demand.
Read all positive factors
TNL Mediagene (TNMG) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$1.28M
Dividend YieldN/A
Average Volume (3M)16.29M
Price to Earnings (P/E)―
Beta (1Y)2.98
Revenue Growth-7.16%
EPS Growth71.12%
CountryUS
Employees500
SectorGeneral
Sector StrengthN/A
IndustryPublishing
Share Statistics
EPS (TTM)N/A
Shares Outstanding2,931,258
10 Day Avg. Volume20,201,232
30 Day Avg. Volume16,293,268
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)5.11
Price to Sales (P/S)0.10
P/FCF Ratio-0.89
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda>-0.01
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
TNL Mediagene Business Overview & Revenue Model
Company Description
TNL Mediagene is a prominent media firm with operations spanning Taiwan and Japan. The company boasts an extensive portfolio of digital publications and platforms. These include general news outlets like The News Lens and Sirabee (covering enterta...
How the Company Makes Money
TNMG primarily generates revenue by monetizing its owned and operated digital media properties and by providing marketing solutions to advertisers. Key revenue streams typically include: (1) digital advertising sold against traffic and engagement ...
TNL Mediagene Financial Statement Overview
Summary
Income Statement
12
Very Negative
Balance Sheet
22
Negative
Cash Flow
15
Very Negative
| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|
Income Statement | ||||
| Total Revenue | 45.02M | 48.49M | 35.84M | 20.01M |
| Gross Profit | 13.98M | 17.74M | 12.65M | 7.74M |
| EBITDA | -45.60M | -73.92M | 1.33M | -10.01M |
| Net Income | -44.55M | -85.00M | -804.98K | -11.01M |
Balance Sheet | ||||
| Total Assets | 49.95M | 92.92M | 119.62M | 26.53M |
| Cash, Cash Equivalents and Short-Term Investments | 2.91M | 3.65M | 3.03M | 3.91M |
| Total Debt | 21.62M | 23.14M | 17.59M | 6.71M |
| Total Liabilities | 49.03M | 56.51M | 47.25M | 50.67M |
| Stockholders Equity | 919.25K | 36.40M | 72.62M | -25.30M |
Cash Flow | ||||
| Free Cash Flow | -5.30M | -10.30M | -1.68M | -1.04M |
| Operating Cash Flow | -4.90M | -10.21M | -1.42M | -760.11K |
| Investing Cash Flow | -897.27K | 947.95K | 252.74K | -2.36M |
| Financing Cash Flow | 3.93M | 10.00M | 530.97K | 4.99M |
TNL Mediagene Technical Analysis
Negative
0.58
Price Trends
0.46
Negative
0.63
Negative
1.95
Negative
Market Momentum
<0.01
Negative
47.32
Neutral
17.50
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TNMG, the sentiment is Negative. The current price of 0.58 is above the 20-day moving average (MA) of 0.45, above the 50-day MA of 0.46, and below the 200-day MA of 1.95, indicating a bearish trend. The MACD of <0.01 indicates Negative momentum. The RSI at 47.32 is Neutral, neither overbought nor oversold. The STOCH value of 17.50 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for TNMG.
TNL Mediagene Risk Analysis
TNL Mediagene disclosed 54 risk factors in its most recent earnings report. TNL Mediagene reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks
TNL Mediagene Peers Comparison
UnderperformOutperform
Sector (55)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% | |
44 Neutral | $4.66M | -4.14 | -20.50% | ― | -55.14% | 86.77% | |
42 Neutral | $1.28M | -0.02 | -198.37% | ― | -7.16% | 71.12% | |
42 Neutral | $1.57M | -0.05 | 570.82% | ― | -15.24% | 61.99% | |
31 Underperform | $2.85M | -2.45 | -43.19% | ― | -8.74% | 88.46% |
* General Sector Average
TNMG
TNL Mediagene
0.44
-5.76
-92.95%
CNET
ZW Data Action Technologies
1.27
-0.20
-13.61%
BAOS
Baosheng Media Group Holdings
0.33
-2.74
-89.38%
DRCT
Direct Digital Holdings
1.96
-91.54
-97.90%
VSME
VS Media Holdings Limited Class A
1.03
-47.57
-97.88%
TNL Mediagene Corporate Events
TNL Mediagene Wins Conditional Nasdaq Listing Extension After Delisting Threat
Aug 25, 2026
On August 23, 2026, TNL Mediagene received a written decision from the Nasdaq Hearings Panel granting its request to remain listed on the Nasdaq Capital Market, following a hearing held on August 4, 2026. The continued listing is conditional on th...
TNL Mediagene Forms Special Committee to Review Strategic Options
Aug 3, 2026
On August 3, 2026, TNL Mediagene said its board had formed a special committee of independent directors to examine strategic transactions and alternatives, ranging from financing and recapitalization to potential mergers, business combinations or ...
TNL Mediagene Retires Convertible Notes and Ends 3i Financing Pact
Jul 29, 2026
On July 8, 2026, TNL Mediagene fully repaid its $1,666,667 senior convertible note issued to 3i, LP, including $150,000.03 of accrued interest, through a combination of cash and 3,381,700 ordinary shares. This repayment followed the earlier Novemb...
TNL Mediagene Faces Nasdaq Delisting After Bid-Price and Equity Breaches
Jun 26, 2026
On June 22, 2026, TNL Mediagene received a staff determination letter from Nasdaq stating that its ordinary shares are subject to delisting from The Nasdaq Capital Market. Nasdaq cited the company’s failure to maintain a minimum $1.00 bid pr...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.